
Advanced Oncotherapy Plc
(LSE) AVO
Advanced Oncotherapy Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$29.49M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AVO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Advanced Oncotherapy Plc
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Nicolas Serandour
Website
advancedoncotherapy.comHeadquarters
London, W1S 1TE, GB
AVO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-67%
Return on Capital
-19%
Return on Assets
-25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.34M
Operating Income
$23.74M
EBITDA
$21.40M
Operating Cash Flow
$29.57M
Capital Expenditure
$9.29M
Free Cash Flow
$38.86M
Cash & ST Invst.
$4.26M
Total Debt
$53.36M
Advanced Oncotherapy Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.27M
+207.6%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
174
N/A
Net Income
$15.88M
+221.1%
EBITDA
$12.26M
+231.8%
Quarterly Fundamentals
Net Cash
$57.24M
-41.6%
Accounts Receivable
$847.71K
-16.1%
Inventory
$29.43M
+56.5%
Long Term Debt
$45.32M
+27.2%
Short Term Debt
$14.42M
+36.8%
Return on Assets
-24.95%
N/A
Return on Invested Capital
-18.96%
N/A
Free Cash Flow
$12.59M
+176.2%
Operating Cash Flow
$7.44M
+160.1%